Articles & courses

ArticlesShow all 223
Ezetimibe: Place in Therapy and Expected LDL-C Reduction

…Definition and pharmacological basis Ezetimibe is a non statin lipid lowering agent that inhibits the Niemann–Pick C1 like 1 (NPC1L1) transporter in the intestine…

NSTEMI (Non-ST Elevation Myocardial Infarction) & Unstable Angina: Diagnosis, Criteria, ECG, Management

…on the other hand, is caused by a complete coronary artery occlusion, which results in the complete stop of blood flow and thus more extensive…

Digoxin: Dosing, Therapeutic Range and Toxicity Management

…Its primary clinical utility in contemporary practice is late line therapy for patients who remain profoundly symptomatic despite optimal neurohormonal blockade and adequate volume control…

Central venous catheter

…arrest and in the uncontrolled emergency — but it should be changed or removed once the situation has stabilised. Preparation and equipment A central line set…

Lumbar puncture

…be measured in the sitting position . 2. Identify the level. Palpate both iliac crests and draw an imaginary line between them. The line crosses the…

Upper gastrointestinal bleeding: quick reference

…mortality than non variceal bleeding [1,2]. Upper gastrointestinal bleeding can present as haematemesis, coffee ground vomiting or melaena. Haematochezia can occur in massive upper…

Coronary Artery Disease

…likely that the coming guidelines by the American Heart Association (AHA) and American College of Cardiology (ACC) will be in line with the European guidelines…

Stable Coronary Artery Disease (Angina Pectoris): Diagnosis, Evaluation, Management

…likely that the coming guidelines by the American Heart Association (AHA) and American College of Cardiology (ACC) will be in line with the European guidelines…

Inclisiran and Emerging Lipid-Lowering Agents

…with reported reductions of up to 50–55% in guideline summaries. It also lowers non HDL C by up to approximately 50% and apolipoprotein B…

ECG changes caused by antiarrhythmic drugs, beta blockers & calcium channel blockers

…WPW syndrome) and other conditions involving an accessory pathway. Paroxysmal atrial fibrillation in patients with severe symptoms, provided that first line therapies have failed and…

Media

No matches.

Tests

Tools